These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2714458)

  • 1. Can thyroxine halt the progression of peripheral arterial disease?
    Powell JT; Wiseman SA; Carter G; Alaghband Zadeh J; Fowler PB; Greenhalgh RM
    Eur J Vasc Surg; 1989 Feb; 3(1):85-7. PubMed ID: 2714458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raised serum thyrotrophin in women with peripheral arterial disease.
    Powell J; Zadeh JA; Carter G; Greenhalgh RM; Fowler PB
    Br J Surg; 1987 Dec; 74(12):1139-41. PubMed ID: 3427361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased HDL cholesterol in subclinical hypothyroidism: the effect of L-thyroxine therapy.
    Caron P; Calazel C; Parra HJ; Hoff M; Louvet JP
    Clin Endocrinol (Oxf); 1990 Oct; 33(4):519-23. PubMed ID: 2121398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).
    Meier C; Staub JJ; Roth CB; Guglielmetti M; Kunz M; Miserez AR; Drewe J; Huber P; Herzog R; Müller B
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4860-6. PubMed ID: 11600554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of lipoproteins and apolipoproteins in congenital hypothyroidism: effects of L-thyroxine substitution therapy.
    Barbagallo CM; Averna MR; Liotta A; La Grutta S; Maggio C; Casimiro L; Cefalù AB; Notarbartolo A
    Metabolism; 1995 Oct; 44(10):1283-7. PubMed ID: 7476285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disturbed lipid metabolism in patients with subclinical hypothyroidism: effect of L-thyroxine therapy.
    Miura S; Iitaka M; Yoshimura H; Kitahama S; Fukasawa N; Kawakami Y; Sakurai S; Urabe M; Sakatsume Y; Ito K
    Intern Med; 1994 Jul; 33(7):413-7. PubMed ID: 7949641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lipids and apolipoproteins A-I, A-II and B in primary hypothyroidism before and during treatment.
    Muls E; Rosseneu M; Blaton V; Lesaffre E; Lamberigts G; de Moor P
    Eur J Clin Invest; 1984 Feb; 14(1):12-5. PubMed ID: 6421595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle-aged women: associations with serum lipids.
    Geul KW; van Sluisveld IL; Grobbee DE; Docter R; de Bruyn AM; Hooykaas H; van der Merwe JP; van Hemert AM; Krenning EP; Hennemann G
    Clin Endocrinol (Oxf); 1993 Sep; 39(3):275-80. PubMed ID: 8222290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical hypothyroidism and hyperlipoproteinaemia: indiscriminate L-thyroxine treatment not justified.
    Bogner U; Arntz HR; Peters H; Schleusener H
    Acta Endocrinol (Copenh); 1993 Mar; 128(3):202-6. PubMed ID: 8480467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of long-term thyroxine on bone mineral density and serum cholesterol.
    Fowler PB; McIvor J; Sykes L; Macrae KD
    J R Coll Physicians Lond; 1996; 30(6):527-32. PubMed ID: 8961207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Selected Atherosclerosis Risk Factors in Women with Subclinical Hypothyroidism Treated with L-Thyroxine.
    Adamarczuk-Janczyszyn M; Zdrojowy-Wełna A; Rogala N; Zatońska K; Bednarek-Tupikowska G
    Adv Clin Exp Med; 2016; 25(3):457-63. PubMed ID: 27629733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroxine replacement therapy and circulating lipid concentrations.
    Franklyn JA; Daykin J; Betteridge J; Hughes EA; Holder R; Jones SR; Sheppard MC
    Clin Endocrinol (Oxf); 1993 May; 38(5):453-9. PubMed ID: 8330440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High serum cholesterol levels in persons with 'high-normal' TSH levels: should one extend the definition of subclinical hypothyroidism?
    Michalopoulou G; Alevizaki M; Piperingos G; Mitsibounas D; Mantzos E; Adamopoulos P; Koutras DA
    Eur J Endocrinol; 1998 Feb; 138(2):141-5. PubMed ID: 9506856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of remnant lipoprotein cholesterol concentrations by cilostazol in patients with intermittent claudication.
    Wang T; Elam MB; Forbes WP; Zhong J; Nakajima K
    Atherosclerosis; 2003 Dec; 171(2):337-42. PubMed ID: 14644405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-course of alterations of high density lipoproteins (HDL) during thyroxine administration to hypothyroid women.
    Verdugo C; Perrot L; Ponsin G; Valentin C; Berthezene F
    Eur J Clin Invest; 1987 Aug; 17(4):313-6. PubMed ID: 3117568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age and gender substantially influence the relationship between thyroid status and the lipoprotein profile: results from a large cross-sectional study.
    Tognini S; Polini A; Pasqualetti G; Ursino S; Caraccio N; Ferdeghini M; Monzani F
    Thyroid; 2012 Nov; 22(11):1096-103. PubMed ID: 23050788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study.
    Iqbal A; Jorde R; Figenschau Y
    J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. Journal of the American Medical Association 2013; 309: 453-460.
    Kurklinsky AK; Levy M
    Vasc Med; 2013 Aug; 18(4):234-6. PubMed ID: 23867841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipids and apolipoprotein profiles in men with aneurysmal and stenosing aorto-iliac atherosclerosis.
    McConathy WJ; Alaupovic P; Woolcock N; Laing SP; Powell J; Greenhalgh R
    Eur J Vasc Surg; 1989 Dec; 3(6):511-4. PubMed ID: 2625160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders.
    Bartalena L; Martino E; Falcone M; Buratti L; Grasso L; Mammoli C; Pacchiarotti A; Aghini-Lombardi F; Balzano S; Pinchera A
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1265-71. PubMed ID: 3680483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.